Jianerkang Medical Co.,Ltd. (SHA:603205)
China flag China · Delayed Price · Currency is CNY
20.63
-0.13 (-0.63%)
At close: Nov 17, 2026

Jianerkang Medical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
490.88764.91721.81226.24178.2597.8
Cash & Short-Term Investments
776.99764.91721.81226.24178.2597.8
Cash Growth
5.54%5.97%219.05%26.92%82.27%3.28%
Accounts Receivable
225.82255.99212.32235.5189.16138.75
Other Receivables
9.911.9914.49.044.436.96
Receivables
235.72267.98226.72244.54193.59145.71
Inventory
209.67167.02176.3158.41170.44158.62
Prepaid Expenses
-0.25-0.529.010.09
Other Current Assets
15.059.4410.3211.0720.718.39
Total Current Assets
1,2371,2101,135640.78572.01410.6
Property, Plant & Equipment
439.33380.05365.42383.67356.1326.67
Other Intangible Assets
56.157.3258.4159.9261.3963.19
Long-Term Deferred Tax Assets
24.5325.9323.0223.1225.9624.37
Long-Term Deferred Charges
31.4533.046.63.022.092.07
Other Long-Term Assets
1.854.671.973.0610.9313.52
Total Assets
1,7911,7111,5911,1141,028840.43

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
162.2796.3887.33103.1495.2573.14
Accrued Expenses
17.8637.1227.734.0742.331.45
Short-Term Debt
----30.0450.05
Current Portion of Leases
5.415.23----
Current Income Taxes Payable
5.045.373.447.784.771.43
Current Unearned Revenue
8.216.196.484.328.854.59
Other Current Liabilities
2.4316.99.7916.4721.9814.76
Total Current Liabilities
201.21167.18134.74165.79203.19175.42
Long-Term Leases
12.5616.54----
Long-Term Unearned Revenue
28.583134.6438.2441.847.76
Long-Term Deferred Tax Liabilities
2.131.451.060.190.190.2
Total Liabilities
244.48216.16170.43204.22245.18223.39

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
156156120909090
Additional Paid-In Capital
685.07680.37710.69350.13347.62338.7
Retained Earnings
708.18658.76589.44469.22345.68188.34
Comprehensive Income & Other
-3.05-0.67-0---
Shareholders' Equity
1,5461,4941,420909.35783.29617.04
Total Liabilities & Equity
1,7911,7111,5911,1141,028840.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
17.9721.76--30.0450.05
Net Cash (Debt)
759.02743.15721.81226.24148.2147.75
Net Cash Growth
6.21%2.96%219.05%52.65%210.40%89.99%
Net Cash Per Share
4.854.735.821.931.270.41
Filing Date Shares Outstanding
156156156117117117
Total Common Shares Outstanding
156156156117117117
Working Capital
1,0361,0421,000474.99368.82235.18
Book Value Per Share
9.919.589.107.776.705.27
Tangible Book Value
1,4901,4371,362849.43721.91553.85
Tangible Book Value Per Share
9.559.218.737.266.174.73
Buildings
-295.88295.48294.63241.34233.68
Machinery
-354.99346.13321.4303.54259.27
Construction In Progress
-26.994.9711.917.367.33